Loading clinical trials...
Loading clinical trials...
The purpose of the study is to determine which combination of neuromuscular blocking agent and reversal agent is safer to use during anesthesia for patients with chronic kidney disease. The main quest...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Texas Medical Branch, Galveston
NCT05993390 · Neuromuscular Blockade, Critical Illness, and more
NCT07569952 · Sphenopalatine Ganglion Block, General Anesthesia, and more
NCT07536568 · Sublingual, Caffeine, and more
NCT07454629 · Bispectral Index Variability During General Anesthesia and Postoperative Recovery, Cholecystectomy, Laparoscopic
NCT06906263 · Anesthesia Complication, Tracheostomy Complications, and more
University of Texas Medical Branch
Galveston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions